Article Text
Therapeutics
Randomised controlled trial
Oral rivaroxaban for acute DVT, or long term for VTE, is as effective as enoxaparin followed by a vitamin K antagonist for preventing recurrence, with no increase in bleeding complications
Statistics from Altmetric.com
Footnotes
-
Competing interests DR has served on speakers bureau of Sanofi Aventis, has received research grant support from Sanofi Aventis and serves on an advisory board for Canyon Pharmaceuticals. JA has served as a consultant for Boehringer Ingelheim, Bristol Myers Squibb, Daiichi Sankyo and Ortho McNeil.